CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 63 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,291,437 | -29.2% | 517,244 | +3.0% | 0.00% | -40.0% |
Q2 2023 | $15,958,039 | +34.4% | 501,983 | +3.1% | 0.01% | +25.0% |
Q1 2023 | $11,877,516 | -22.4% | 486,983 | +0.3% | 0.00% | -20.0% |
Q4 2022 | $15,307,750 | +15.8% | 485,344 | +3.8% | 0.01% | 0.0% |
Q3 2022 | $13,220,000 | +26.4% | 467,786 | +18.3% | 0.01% | +25.0% |
Q2 2022 | $10,457,000 | -19.8% | 395,485 | +6.2% | 0.00% | 0.0% |
Q1 2022 | $13,044,000 | +10.8% | 372,561 | +2.6% | 0.00% | +33.3% |
Q4 2021 | $11,773,000 | +13.4% | 363,120 | +3.2% | 0.00% | 0.0% |
Q3 2021 | $10,379,000 | +61.1% | 351,808 | +39.9% | 0.00% | +50.0% |
Q2 2021 | $6,444,000 | +173.3% | 251,493 | +46.5% | 0.00% | +100.0% |
Q1 2021 | $2,358,000 | -14.7% | 171,670 | +3.0% | 0.00% | 0.0% |
Q4 2020 | $2,765,000 | – | 166,710 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,005,284,000 | 38.09% |
Ally Bridge Group (NY) LLC | 1,767,440 | $29,304,000 | 5.02% |
Affinity Asset Advisors, LLC | 270,000 | $4,477,000 | 2.37% |
SPHERA FUNDS MANAGEMENT LTD. | 811,665 | $13,457,000 | 1.19% |
Artal Group S.A. | 2,282,100 | $37,837,000 | 0.81% |
Perceptive Advisors | 4,544,062 | $75,340,000 | 0.81% |
RA Capital Management | 2,200,000 | $36,476,000 | 0.51% |
Monashee Investment Management LLC | 200,000 | $3,316,000 | 0.44% |
Boxer Capital, LLC | 714,500 | $11,846,000 | 0.38% |
EcoR1 Capital, LLC | 400,000 | $6,632,000 | 0.36% |